{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:09:14Z","timestamp":1716800954852},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2007,4,27]],"date-time":"2007-04-27T00:00:00Z","timestamp":1177632000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharm World Sci"],"published-print":{"date-parts":[[2007,10,15]]},"DOI":"10.1007\/s11096-007-9129-8","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T08:53:29Z","timestamp":1177577609000},"page":"683-687","source":"Crossref","is-referenced-by-count":1,"title":["Information provided by generic and brand-name pharmaceutical manufacturers in response to a request"],"prefix":"10.1007","volume":"29","author":[{"given":"Fernando","family":"Fernandez-Llimos","sequence":"first","affiliation":[]},{"given":"Isabel","family":"Vazquez Gomez","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,4,27]]},"reference":[{"issue":"24","key":"9129_CR1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJM198306163082406","volume":"308","author":"J Avorn","year":"1983","unstructured":"Avorn J, Soumerai SB. Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based \u201cdetailing\u201d. N Engl J Med 1983;308(24):1457\u201363.","journal-title":"N Engl J Med"},{"issue":"5","key":"9129_CR2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1136\/dtb.1994.32535","volume":"32","author":"Anonymous","year":"1994","unstructured":"Anonymous. Talking about drug treatments-who should say what to whom? the second DTB symposium. Drug Ther Bull 1994;32(5):35\u20137.","journal-title":"Drug Ther Bull"},{"issue":"1","key":"9129_CR3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/0003-4819-108-1-145","volume":"108","author":"Health and Public Policy Committee, American College of Physicians","year":"1988","unstructured":"Health and Public Policy Committee, American College of Physicians. Improving medical education in therapeutics. Ann Intern Med 1988;108(1):145\u20137.","journal-title":"Ann Intern Med"},{"issue":"9230","key":"9129_CR4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(00)02605-2","volume":"356","author":"B Djulbegovic","year":"2000","unstructured":"Djulbegovic B, Lacevic M, Cantor A, Fields KK, Bennett CL, Adams JR, Kuderer NM, Lyman GH. The uncertainty principle and industry-sponsored research. Lancet 2000;356(9230):635\u20138.","journal-title":"Lancet"},{"issue":"7400","key":"9129_CR5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1136\/bmj.326.7400.1156","volume":"326","author":"A Liberati","year":"2003","unstructured":"Liberati A, Magrini N. Information from drug companies and opinion leaders. BMJ 2003;326(7400):1156\u20137.","journal-title":"BMJ"},{"issue":"1","key":"9129_CR6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/fampra\/20.1.61","volume":"20","author":"H Prosser","year":"2003","unstructured":"Prosser H, Almond S, Walley T. Influences on GPs\u2019 decision to prescribe new drugs-the importance of who says what. Fam Pract 2003;20(1):61\u20138.","journal-title":"Fam Pract"},{"key":"9129_CR7","unstructured":"World Health Organization. Conference of Experts on the Rational Use of Drugs. Nairobi, Kenya; 1985. p. 25\u201329 November."},{"key":"9129_CR8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2296-7-13","volume":"7","author":"R Cardarelli","year":"2006","unstructured":"Cardarelli R, Licciardone JC, Taylor LG. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?. BMC Fam Pract 2006;7:13.","journal-title":"BMC Fam Pract"},{"issue":"4","key":"9129_CR9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1503\/cmaj.1031940","volume":"172","author":"RJ Cooper","year":"2005","unstructured":"Cooper RJ, Schriger DL. The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. CMAJ 2005;172(4):487\u201391.","journal-title":"CMAJ"},{"key":"9129_CR10","unstructured":"Council Directive 83\/570\/EEC of 26 October 1983 amending Directives 65\/65\/EEC, 75\/318\/EEC and 75\/319\/EEC on the approximation of provisions laid down by law, regulation or administrative action relating to proprietary medicinal products. Official Journal L 332, 28\/11\/1983 p. 1\u201310."},{"issue":"3","key":"9129_CR11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1345\/aph.18421","volume":"34","author":"F Fernandez-Llimos","year":"2000","unstructured":"Fernandez-Llimos F, Loza MI. Product monographs supplied by drug manufacturers to community pharmacists in Spain. Ann Pharmacother 2000;34(3):407.","journal-title":"Ann Pharmacother"},{"issue":"7","key":"9129_CR12","first-page":"288","volume":"89","author":"P Castillo Perez","year":"1987","unstructured":"Castillo Perez P. [Pharmacological information and the drug industry. The role of its medical departments]. Med Clin (Barc) 1987;89(7):288\u201395.","journal-title":"Med Clin (Barc)"},{"key":"9129_CR13","unstructured":"Council Directive 92\/28\/EEC of 31 March 1992 on the advertising of medicinal products for human use. Official Journal L 113 of 30.4.1992, p. 13."},{"key":"9129_CR14","unstructured":"Council Directive 75\/319\/EEC of 20 May 1975 on the approximation of provisions laid down by law, regulation or administrative action relating to medicinal products. Official Journal L 147 of 9.6.1975."},{"issue":"11","key":"9129_CR15","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1177\/106002809402801102","volume":"28","author":"A Keng","year":"1994","unstructured":"Keng A, Coley RM. Evaluating the accuracy of citations in drug promotional brochures. Ann Pharmacother 1994;28(11):1231\u20135.","journal-title":"Ann Pharmacother"},{"issue":"4","key":"9129_CR16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1157\/13072596","volume":"35","author":"I Vazquez Gomez","year":"2005","unstructured":"Vazquez Gomez I, Fernandez-Llimos F, Gastelurrutia MA. Response of the pharmaceutical industry to a specific consultation. Aten Primaria 2005; 35(4): 219\u201320.","journal-title":"Aten Primaria"}],"container-title":["Pharmacy World & Science"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-007-9129-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-007-9129-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-007-9129-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T05:51:31Z","timestamp":1559368291000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-007-9129-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4,27]]},"references-count":16,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,10,15]]}},"alternative-id":["9129"],"URL":"https:\/\/doi.org\/10.1007\/s11096-007-9129-8","relation":{},"ISSN":["0928-1231","1573-739X"],"issn-type":[{"value":"0928-1231","type":"print"},{"value":"1573-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,4,27]]}}}